O

OrbiMed Portfolio holdings

AUM $3.98B
1-Year Est. Return 13.05%
This Quarter Est. Return
1 Year Est. Return
+13.05%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$8.28B
AUM Growth
+$422M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
137
New
Increased
Reduced
Closed

Top Buys

1
+$120M
2
+$74.9M
3
+$73.6M
4
TRNX
TORNIER N V SHARES (NLD)
TRNX
+$60.8M
5
BMY icon
Bristol-Myers Squibb
BMY
+$59.3M

Top Sells

1
+$156M
2
+$123M
3
+$72.4M
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$60M
5
XLRN
Acceleron Pharma
XLRN
+$57.6M

Sector Composition

1 Healthcare 84.96%
2 Financials 0.08%
3 Technology 0.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$391M 4.59%
1,656,258
-78,676
2
$349M 4.09%
7,189,000
+1,222,600
3
$342M 4.01%
1,084,200
+23,500
4
$294M 3.45%
5,204,200
+410,400
5
$285M 3.34%
3,434,800
-1,880,000
6
$266M 3.12%
2,245,000
-70,900
7
$261M 3.07%
1,543,700
-726,300
8
$254M 2.99%
4,513,000
+298,000
9
$247M 2.91%
1,424,808
+26,214
10
$242M 2.84%
9,941,551
11
$240M 2.81%
5,425,200
-526,800
12
$228M 2.68%
2,655,000
-87,800
13
$213M 2.5%
905,200
+318,200
14
$204M 2.39%
3,952,700
+47,200
15
$198M 2.32%
3,500,400
+376,400
16
$189M 2.21%
4,893,200
-555,000
17
$181M 2.13%
1,535,700
+142,500
18
$180M 2.11%
4,376,159
+122,604
19
$172M 2.02%
1,181,700
+124,900
20
$163M 1.91%
3,671,000
+1,659,000
21
$162M 1.91%
5,415,600
+70,000
22
$161M 1.89%
3,519,900
+493,200
23
$147M 1.72%
2,659,824
-9,432
24
$144M 1.69%
2,079,000
-18,000
25
$137M 1.61%
10,669,465
+9,377,438
1
2 3 4 5